Save
Share
Successful treatment of acquired von Willebrand syndrome secondary to low-grade CLL with rituximab and venetoclax.
Journal:
Leukemia & Lymphoma
Published:
August 19, 2024
Authors
Aaron Boothby
,
Livia Hegerova
, Shelley Fletcher,
Mazyar Shadman
,
Jill Johnsen
Relevant Conditions
Leukemia
View Article From Source
Similar Publications
We couldn’t find any related articles. Please check for more on the main search page.